Skip to content
Home/Companies/MedTech/Immed
Immed

Immed

MedTech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Immed?

Immed is currently owned by Isatis Capital through FCPR Isatis Capital Vie & Retraite (2017 vintage), since 2022.

Hand-verified · updated 2026-04-21

Isatis Capital
Investor
Isatis Capital
FCPR Isatis Capital Vie & Retraite · 2017 · Growth

Key facts

HQFrance
SectorMedTech
Websitewww.immed.net

More from FCPR Isatis Capital Vie & Retraite

Other portfolio companies in the same fund.

Adelyce
Active
HR TechFrance· 2026
Captivea
Active
IT ServicesFrance· 2026
AXE Informatique
AXE Informatique
Active
IT ServicesFrance· 2025
One Prepaid
One Prepaid
Active
FintechFrance· 2025
Sources
Active
IndustrialsFrance· 2025
2AST
2AST
Active
IndustrialsFrance· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Immed

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Immed?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Immed.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue